Skip to content
10-Q

Quarterly Report

MABVAX THERAPEUTICS HOLDINGS, INC.

0001654954-18-012555

← back to feed
Filed
Nov 13, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 13, 2018 9.25M sh
Shares Diluted Q3 2018 · Sep 30, 2018 17.12M sh
Shares Diluted Q3 2018 · Sep 30, 2018 8.98M sh
Shares Diluted Q3 2018 · Sep 30, 2017 3.83M sh
Shares Diluted Q3 2018 · Sep 30, 2017 2.83M sh
Capex Q3 2018 · Sep 30, 2018 $0
Capex Q3 2018 · Sep 30, 2017 $21.07K
Long Term Debt Q3 2018 · Sep 30, 2018 $2.81M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $951.75K
Cash And Equivalents Q3 2018 · Dec 31, 2017 $885.71K
Cash And Equivalents Q3 2018 · Sep 30, 2017 $3.05M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $3.98M
Stockholders Equity Q3 2018 · Sep 30, 2018 $42.56K
Stockholders Equity Q3 2018 · Dec 31, 2017 $1.13M
Current Liabilities Q3 2018 · Sep 30, 2018 $7.77M
Current Liabilities Q3 2018 · Dec 31, 2017 $5.81M
Total Liabilities Q3 2018 · Sep 30, 2018 $8.85M
Total Liabilities Q3 2018 · Dec 31, 2017 $7.66M
Current Assets Q3 2018 · Sep 30, 2018 $1.44M
Current Assets Q3 2018 · Dec 31, 2017 $1.21M
Total Assets Q3 2018 · Sep 30, 2018 $8.9M
Total Assets Q3 2018 · Dec 31, 2017 $8.79M
Eps Diluted Q3 2018 · Sep 30, 2018 $0.02
Eps Diluted Q3 2018 · Sep 30, 2018 −$0.81
Eps Diluted Q3 2018 · Sep 30, 2017 −$1.62
Eps Diluted Q3 2018 · Sep 30, 2017 −$8.04
Eps Basic Q3 2018 · Sep 30, 2018 $0.04
Eps Basic Q3 2018 · Sep 30, 2018 −$0.81
Eps Basic Q3 2018 · Sep 30, 2017 −$1.62
Eps Basic Q3 2018 · Sep 30, 2017 −$8.04
Sga Expense Q3 2018 · Sep 30, 2018 $2.52M
Sga Expense Q3 2018 · Sep 30, 2018 $6.41M
Sga Expense Q3 2018 · Sep 30, 2017 $1.83M
Sga Expense Q3 2018 · Sep 30, 2017 $7.51M
Rd Expense Q3 2018 · Sep 30, 2018 $199.37K
Rd Expense Q3 2018 · Sep 30, 2018 $2.92M
Rd Expense Q3 2018 · Sep 30, 2017 $1.02M
Rd Expense Q3 2018 · Sep 30, 2017 $6.17M
Net Income Q3 2018 · Sep 30, 2018 $340.68K
Net Income Q3 2018 · Sep 30, 2018 −$5.91M
Net Income Q3 2018 · Sep 30, 2017 −$3.08M
Net Income Q3 2018 · Sep 30, 2017 −$14.42M
Operating Income Q3 2018 · Sep 30, 2018 $494.68K
Operating Income Q3 2018 · Sep 30, 2018 −$5.41M
Operating Income Q3 2018 · Sep 30, 2017 −$2.85M
Operating Income Q3 2018 · Sep 30, 2017 −$13.68M
Gross Profit Q3 2018 · Sep 30, 2018 $3.22M
Gross Profit Q3 2018 · Sep 30, 2018 $3.92M
Gross Profit Q3 2018 · Sep 30, 2017 $0
Gross Profit Q3 2018 · Sep 30, 2017 $0
Cost Of Revenue Q3 2018 · Sep 30, 2018 $785K
Cost Of Revenue Q3 2018 · Sep 30, 2018 $785K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $0
Cost Of Revenue Q3 2018 · Sep 30, 2017 $0
Revenue Q3 2018 · Sep 30, 2018 $4M
Revenue Q3 2018 · Sep 30, 2018 $4.7M
Revenue Q3 2018 · Sep 30, 2017 $0
Revenue Q3 2018 · Sep 30, 2017 $0